NASDAQ : ENTA
Enanta Pharmaceuticals, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 10.71 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 311.93M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Enanta Pharmaceuticals, Inc. (ENTA) reported revenue of 65.26M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year October - September; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Operating Revenue | 65.26M | 65.32M | 67.64M | 79.20M | 86.16M | 97.07M |
| Revenue | 65.26M | 65.32M | 67.64M | 79.20M | 86.16M | 97.07M |
| Gross Profit | 65.26M | 65.32M | 67.64M | 79.20M | 86.16M | 97.07M |
| Selling, General & Admin | 37.75M | 43.93M | 57.85M | 52.89M | 45.48M | 32.54M |
| Research & Development | 86.24M | 106.74M | 131.48M | 163.52M | 164.52M | 174.11M |
| Operating Expenses | 123.98M | 150.67M | 189.33M | 216.41M | 210.00M | 206.65M |
| Operating Income | -58.73M | -85.35M | -121.69M | -137.21M | -123.84M | -109.57M |
| Interest Expense | -12.92M | -7.68M | -10.94M | -5.15M | ||
| Interest & Investment Income | 7.84M | 9.95M | 13.63M | 8.50M | 2.74M | 2.02M |
| Other Non Operating Income (Expenses) | 39.00K | 39.00K | 73.00K | 83.00K | -27.00K | |
| EBT Excluding Unusual Items | -63.76M | -83.05M | -118.93M | -133.85M | -121.02M | -107.58M |
| Gain (Loss) on Sale of Investments | 628.00K | -503.00K | 1.14M | 2.86M | -1.17M | |
| Pretax Income | -63.13M | -83.55M | -117.79M | -131.00M | -122.19M | -107.58M |
| Income Tax Expense | 99.00K | -1.66M | -1.74M | 2.82M | -433.00K | -28.58M |
| Net Income | -63.23M | -81.89M | -116.05M | -133.82M | -121.75M | -79.00M |
| Net Income to Common | -63.23M | -81.89M | -116.05M | -133.82M | -121.75M | -79.00M |
| Shares Outstanding (Basic) | 27.06M | 21.34M | 21.16M | 20.97M | 20.60M | 20.17M |
| Shares Outstanding (Diluted) | 27.06M | 21.34M | 21.16M | 20.97M | 20.60M | 20.17M |
| EPS (Basic) | -2.34 | -3.84 | -5.48 | -6.38 | -5.91 | -3.92 |
| EPS (Diluted) | -2.34 | -3.84 | -5.48 | -6.38 | -5.91 | -3.92 |
| Free Cash Flow | -36.94M | -32.17M | -96.71M | -112.21M | -86.91M | -70.75M |
| Free Cash Flow Per Share | -1.36 | -1.51 | -4.57 | -5.35 | -4.22 | -3.51 |
| Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| Operating Margin | -89.99% | -130.66% | -179.92% | -173.23% | -143.74% | -112.88% |
| Profit Margin | -96.89% | -125.36% | -171.58% | -168.95% | -141.31% | -81.38% |
| Free Cash Flow Margin | -56.61% | -49.24% | -142.99% | -141.67% | -100.87% | -72.88% |
| EBITDA | -53.82M | -80.76M | -119.36M | -134.84M | -120.87M | -106.24M |
| EBITDA Margin | -82.47% | -123.63% | -176.47% | -170.24% | -140.29% | -109.44% |
| D&A For EBITDA | 4.91M | 4.59M | 2.34M | 2.37M | 2.97M | 3.33M |
| EBIT | -58.73M | -85.35M | -121.69M | -137.21M | -123.84M | -109.57M |
| EBIT Margin | -89.99% | -130.66% | -179.92% | -173.23% | -143.74% | -112.88% |
| Revenue as Reported | 65.26M | 65.32M | 67.64M | 79.20M | 86.16M | 97.07M |
Balance sheet
Fiscal year October - September; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 33.42M | 32.30M | 37.23M | 85.39M | 43.99M | 57.21M |
| Short-Term Investments | 156.09M | 156.57M | 210.95M | 284.52M | 205.24M | 186.80M |
| Cash & Short-Term Investments | 189.51M | 188.86M | 248.19M | 369.91M | 249.23M | 244.00M |
| Accounts Receivable | 6.53M | 6.88M | 6.65M | 8.61M | 20.32M | 23.58M |
| Other Receivables | 32.00M | 31.00M | 28.72M | 37.26M | ||
| Receivables | 6.53M | 6.88M | 38.65M | 39.62M | 49.04M | 60.83M |
| Prepaid Expenses | 7.58M | 8.59M | 12.41M | 13.26M | 13.45M | 14.19M |
| Restricted Cash | 608.00K | |||||
| Total Current Assets | 203.62M | 204.34M | 299.85M | 422.79M | 311.71M | 319.02M |
| Property, Plant & Equipment | 67.79M | 72.94M | 73.35M | 34.71M | 29.75M | 10.65M |
| Long-Term Investments | 21.99M | 29.29M | 108.42M | |||
| Other Long-Term Assets | 3.47M | 3.45M | 3.45M | 4.77M | 4.66M | 700.00K |
| Total Assets | 296.87M | 280.73M | 376.65M | 462.27M | 375.41M | 438.79M |
| Accounts Payable | 3.29M | 1.95M | 8.00M | 4.10M | 6.00M | 9.54M |
| Accrued Expenses | 10.18M | 12.75M | 13.55M | 18.34M | 20.94M | 22.43M |
| Current Portion of Long-Term Debt | 36.78M | 30.71M | 34.46M | 35.08M | ||
| Current Portion of Leases | 3.91M | 3.15M | 1.52M | 5.28M | 2.89M | 4.20M |
| Total Current Liabilities | 54.17M | 48.55M | 57.53M | 62.79M | 29.83M | 36.17M |
| Long-Term Debt | 89.60M | 112.44M | 136.13M | 160.85M | 1.42M | 1.51M |
| Long-Term Leases | 51.75M | 54.76M | 53.94M | 21.24M | 22.37M | 1.13M |
| Other Long-Term Liabilities | 286.00K | 260.00K | 231.00K | 663.00K | 454.00K | 558.00K |
| Total Liabilities | 195.80M | 216.01M | 247.84M | 245.54M | 54.08M | 39.36M |
| Common Stock | 291.00K | 214.00K | 212.00K | 211.00K | 208.00K | 202.00K |
| Additional Paid-In Capital | 551.16M | 469.77M | 451.34M | 424.69M | 398.03M | 351.03M |
| Retained Earnings | -449.46M | -404.93M | -323.04M | -207.00M | -73.18M | 48.58M |
| Comprehensive Income & Other | -927.00K | -339.00K | 302.00K | -1.17M | -3.72M | -382.00K |
| Shareholders' Equity | 101.07M | 64.72M | 128.81M | 216.74M | 321.33M | 399.43M |
| Total Liabilities & Equity | 296.87M | 280.73M | 376.65M | 462.27M | 375.41M | 438.79M |
| Total Debt | 182.04M | 201.06M | 226.06M | 222.44M | 26.69M | 6.83M |
| Net Cash (Debt) | 29.45M | -12.19M | 22.13M | 147.47M | 251.83M | 345.58M |
| Net Cash Per Share | 1.09 | -0.57 | 1.05 | 7.03 | 12.22 | 17.13 |
| Filing Date Shares Outstanding | 29.13M | 28.86M | 21.19M | 21.06M | 20.80M | 20.32M |
| Total Common Shares Outstanding | 29.12M | 21.39M | 21.19M | 21.06M | 20.79M | 20.24M |
| Working Capital | 149.45M | 155.78M | 242.32M | 360.00M | 281.89M | 282.85M |
| Book Value Per Share | 3.47 | 3.03 | 6.08 | 10.29 | 15.46 | 19.74 |
| Tangible Book Value | 101.07M | 64.72M | 128.81M | 216.74M | 321.33M | 399.43M |
| Tangible Book Value Per Share | 3.47 | 3.03 | 6.08 | 10.29 | 15.46 | 19.74 |
| Machinery | 20.39M | 19.92M | 19.14M | 16.79M | 16.32M | |
| Construction In Progress | 22.75M | 1.27M | 2.56M | 20.00K | ||
| Leasehold Improvements | 38.20M | 13.97M | 13.80M | 7.28M | 7.14M |
Cash flow statement
Fiscal year October - September; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -63.23M | -81.89M | -116.05M | -133.82M | -121.75M | -79.00M |
| Depreciation & Amortization | 4.91M | 4.59M | 2.34M | 2.37M | 2.97M | 3.33M |
| Loss (Gain) From Sale of Assets | 6.00K | 16.00K | 150.00K | |||
| Loss (Gain) From Sale of Investments | -1.87M | 503.00K | -1.14M | -2.93M | 325.00K | -1.91M |
| Stock-Based Compensation | 15.28M | 18.57M | 26.80M | 28.22M | 26.97M | 20.99M |
| Other Operating Activities | 4.63M | -952.00K | 2.14M | -5.17M | -83.00K | 275.00K |
| Change in Accounts Receivable | 1.80M | -236.00K | 1.97M | 11.70M | 3.26M | -84.00K |
| Change in Accounts Payable | 616.00K | -1.31M | -414.00K | -1.15M | -4.63M | 3.77M |
| Change in Income Taxes | 24.00K | 32.00M | -995.00K | -2.29M | 8.54M | -24.21M |
| Change in Other Net Operating Assets | 2.53M | 9.46M | 6.57M | -243.00K | -372.00K | 6.84M |
| Operating Cash Flow | -35.32M | -19.27M | -78.76M | -103.15M | -84.78M | -70.00M |
| Capital Expenditures | -1.62M | -12.90M | -17.95M | -9.06M | -2.12M | -750.00K |
| Investment in Securities | -17.43M | 53.24M | 76.18M | -44.52M | 57.02M | 37.74M |
| Investing Cash Flow | -19.05M | 40.35M | 58.23M | -53.58M | 54.90M | 36.99M |
| Issuance of Common Stock | 70.68M | 145.00K | 147.00K | 2.21M | 21.26M | 3.61M |
| Other Financing Activities | -27.70M | -26.76M | -27.77M | 195.92M | -1.23M | -534.00K |
| Financing Cash Flow | 42.98M | -26.62M | -27.63M | 198.13M | 20.03M | 3.08M |
| Net Cash Flow | -11.39M | -5.54M | -48.16M | 41.39M | -9.85M | -29.93M |
| Free Cash Flow | -36.94M | -32.17M | -96.71M | -112.21M | -86.91M | -70.75M |
| Free Cash Flow Margin | -56.61% | -49.24% | -142.99% | -141.67% | -100.87% | -72.88% |
| Free Cash Flow Per Share | -1.36 | -1.51 | -4.57 | -5.35 | -4.22 | -3.51 |
| Levered Free Cash Flow | -22.66M | -18.54M | -71.38M | -62.34M | -42.08M | -57.67M |
| Unlevered Free Cash Flow | -14.58M | -13.74M | -64.55M | -59.13M | -42.08M | -57.67M |
| Cash Interest Paid | 10.37M | 8.79M | 11.71M | 1.99M | ||
| Cash Income Tax Paid | 109.00K | -33.68M | 241.00K | 4.90M | 32.00K | |
| Change in Working Capital | 4.97M | 39.91M | 7.13M | 8.02M | 6.79M | -13.69M |
Ratios
Fiscal year October - September; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 311.93M | 255.89M | 219.51M | 235.19M | 1.07B | 1.15B |
| Enterprise Value | 282.48M | 258.88M | 173.09M | 73.48M | 808.60M | 784.03M |
| Last Close Price | 10.71 | 11.97 | 10.36 | 11.17 | 51.87 | 56.81 |
| Forward PE | 6.26 | 6.26 | 6.26 | 6.26 | 105.09 | |
| PS Ratio | 4.78 | 3.92 | 3.25 | 2.97 | 12.48 | 11.83 |
| PB Ratio | 3.09 | 3.95 | 1.70 | 1.08 | 3.35 | 2.88 |
| P/TBV Ratio | 3.09 | 3.95 | 1.70 | 1.08 | 3.35 | 2.88 |
| PEG Ratio | 1.82 | 1.82 | 1.82 | 1.82 | 1.82 | |
| EV/Sales Ratio | 4.33 | 3.96 | 2.56 | 0.93 | 9.38 | 8.08 |
| Debt / Equity Ratio | 1.80 | 3.11 | 1.75 | 1.03 | 0.08 | 0.02 |
| Net Debt / Equity Ratio | -0.29 | 0.19 | -0.17 | -0.68 | -0.78 | -0.86 |
| Net Debt / EBITDA Ratio | 0.55 | -0.15 | 0.18 | 1.09 | 2.08 | 3.25 |
| Net Debt / FCF Ratio | 0.80 | -0.38 | 0.23 | 1.31 | 2.90 | 4.88 |
| Asset Turnover | 0.22 | 0.20 | 0.16 | 0.19 | 0.21 | 0.21 |
| Quick Ratio | 3.62 | 4.03 | 4.99 | 6.52 | 10.00 | 8.43 |
| Current Ratio | 3.76 | 4.21 | 5.21 | 6.73 | 10.45 | 8.82 |
| Return on Equity (ROE) | -70.12% | -84.63% | -67.16% | -49.74% | -33.78% | -18.48% |
| Return on Assets (ROA) | -12.28% | -16.23% | -18.13% | -20.47% | -19.01% | -14.81% |
| Return on Invested Capital (ROIC) | -50.40% | -92.97% | -138.32% | -163.29% | -94.88% | -91.02% |
| Return on Capital Employed (ROCE) | -24.20% | -36.80% | -38.10% | -34.30% | -35.80% | -27.20% |
| Earnings Yield | -21.82% | -32.00% | -52.86% | -56.90% | -11.33% | -6.88% |
| FCF Yield | -11.84% | -12.57% | -44.06% | -47.71% | -8.08% | -6.16% |
| Buyback Yield / Dilution | -27.12% | -0.85% | -0.90% | -1.78% | -2.14% | -1.16% |